GLOBAL BIODEFENSE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 138

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

Scope of the Report:
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The worldwide market for Biodefense is expected to grow at a CAGR of roughly 8.5% over the next five years, will reach 1390 million US$ in 2024, from 850 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Biodefense in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others

Market Segment by Applications, can be divided into
- US Military Market
- US Civilian Market
- Non - US Market

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biodefense product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biodefense, with price, sales, revenue and global market share of Biodefense in 2017 and 2018.
Chapter 3, the Biodefense competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biodefense breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biodefense market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biodefense sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Mar 19)

An air gun is any kind of gun that launches projectiles pneumatically with compressed air or other gases that are pressurized mechanically w...

(Mar 19)

X-Ray Security Scanner is a machine that offers high energy X-ray systems designed to meet the full range of cargo inspection applications. ...

(Mar 19)

Deployable Military Shelter System is one of such product which is used in applications ranging from temporary medical support centres to in...

(Mar 19)

VHF air-ground communications station is one of the key devices in VHF air-ground communication system for civil aviation air traffic manage...

(Mar 19)

Large caliber ammunition contains gunpowder, explosives or other filler. Large caliber ammunition can damage effect to the target or other t...

(Mar 19)

Body Armor and Personal Protection is an item of personal armor or helmet etc. that helps absorb the impact and reduce or stop penetration t...

GLOBAL BIODEFENSE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Public Sector market as per your needs. Get the best of Public Sector research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy